What to do when you discover testicular cancer: Helping patients overcome fear and choose treatment

Postgraduate Medicine

Volumn 105, Issue 4, 1999, Pages 229-236

  Sonpavde, Guru ^a   Einhorn, Lawrence H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; BLEOMYCIN; CHORIONIC GONADOTROPIN; CISPLATIN; CORTICOSTEROID; ETOPOSIDE; LACTATE DEHYDROGENASE; TUMOR MARKER;

CANCER CLASSIFICATION; CANCER PATIENT; CANCER STAGING; DIAGNOSTIC APPROACH ROUTE; DRUG INDUCED DISEASE; HUMAN; MALE; NEPHROTOXICITY; NEUTROPENIA; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PATIENT CARE; PROGNOSIS; REVIEW; RISK ASSESSMENT; SEMINOMA; TESTIS CANCER; TREATMENT PLANNING;

EID: 0033006059     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1999.04.699     Document Type: Review

References (19)

1. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997;337(4): 242-53
2. Bosl GJ, Bajorin DF, Sheinfeld J, et al. Cancer of the testis. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles & practice of oncology. 5th ed. Philadelphia: Lippincott-Raven, 1997: 1397-426
3. Einhorn LH. Testicular cancer as a model for a curable neoplasm: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1981;41(9 Pt 1): 3275-80
4. O'Callaghan A, Mead GM. Testicular carcinoma. Postgrad Med J 1997;73(862): 481-6
5. Nichols CR, Heerema NA, Palmer C, et al. Klinefelter's syndrome associated with mediastinal germ cell neoplasms. J Clin Oncol 1987;5(8):1290-4
6. Dieckmann KP, Pichlmeier U. The prevalence of familial testicular cancer: an analysis of two patient populations and a review of the literature. Cancer 1997; 80(10):1954-60
7. Nichols CR, Roth BJ, Heerema N, et al. Hematologic neoplasia associated with primary mediastinal germ-cell tumors. N Engl J Med 1990;322(20):1425-9
8. Chaganti RS, Rodriguez E, Bosl GJ. Cytogenetics of male germ-cell tumors. Urol Clin North Am 1993;20(1):55-66
9. International Germ Cell Cancer Collaborative Group. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997; 15(2):594-603
10. Donohue JP, Thornhill JA, Foster RS, et al. Primary retroperitoneal lymph node dissection in clinical stage A nonseminomatous germ cell testis cancer: review of the Indiana University experience 1965-1989. Br J Urol 1993;71(3):326-35
11. Williams SD, Stablein DM, Einhorn LH, et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 1987;317(23):1433-8
12. Einhorn LH, Williams SD, Loehrer PJ, et al. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. J Clin Oncol 1989;7(3):387-91
13. Williams SD, Birch R, Einhorn LH, et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 1987;316(23):1435-40
14. Warde P, Gospodarowicz MK, Panzarella T, et al. Stage I testicular seminoma: results of adjuvant irradiation and surveillance. J Clin Oncol 1995;13(9):2255-62
15. Schultz SM, Einhorn LH, Conces DJ Jr, et al. Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience. J Clin Oncol 1989;7(10):1497-503
16. Einhorn LH, Weathers T, Loehrer PJ, et al. Long term follow up of second line chemotherapy with vinblastine, ifosfamide and cisplatin in disseminated germ cell tumors. (Abstr) Proc ASCO 1996; 15(May):240
17. Broun ER, Nichols CR, Gize G, et al. Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer. Cancer 1997;79(8):1605-10
18. Baniel J, Foster RS, Gonin R, et al. Late relapse of testicular cancer. J Clin Oncol 1995;13(5):1170-6
19. Nichols CR, Breeden ES, Loehrer PJ, et al. Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols. J Natl Cancer Inst 1993;85(1):36-40